Efficacy of an anti-CD22 antibody-monomethyl auristatin E conjugate in a preclinical xenograft model of precursor B-cell acute lymphoblastic leukemia

MLA

Yueju Li, et al. Efficacy of an Anti-CD22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B-Cell Acute Lymphoblastic Leukemia. May 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f95a89ec6f89245197867dce577cb60&authtype=sso&custid=ns315887.

APA

Yueju Li, Laurel A. Beckett, Jong Hee Chung, Emily Tuscano, Noriko Satake, Sakiko Yoshida, Joseph Tuscano, & Connie P.M. Duong. (2017). Efficacy of an anti-CD22 antibody-monomethyl auristatin E conjugate in a preclinical xenograft model of precursor B-cell acute lymphoblastic leukemia.

Chicago

Yueju Li, Laurel A. Beckett, Jong Hee Chung, Emily Tuscano, Noriko Satake, Sakiko Yoshida, Joseph Tuscano, and Connie P.M. Duong. 2017. “Efficacy of an Anti-CD22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B-Cell Acute Lymphoblastic Leukemia,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f95a89ec6f89245197867dce577cb60&authtype=sso&custid=ns315887.